These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19940192)

  • 1. Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.
    Soulika AM; Lee E; McCauley E; Miers L; Bannerman P; Pleasure D
    J Neurosci; 2009 Nov; 29(47):14965-79. PubMed ID: 19940192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
    Bannerman PG; Hahn A
    J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
    Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
    Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
    Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
    J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D; Ayers MM; Catmull DV; Hazelwood LJ; Bernard CC; Orian JM
    Glia; 2005 Aug; 51(3):235-40. PubMed ID: 15812814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
    Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
    Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of progesterone administration on axonal pathology in mice with experimental autoimmune encephalomyelitis.
    Garay L; Gonzalez Deniselle MC; Meyer M; Costa JJ; Lima A; Roig P; De nicola AF
    Brain Res; 2009 Aug; 1283():177-85. PubMed ID: 19497309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.
    Kerstetter AE; Padovani-Claudio DA; Bai L; Miller RH
    Exp Neurol; 2009 Nov; 220(1):44-56. PubMed ID: 19616545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
    Jackson SJ; Lee J; Nikodemova M; Fabry Z; Duncan ID
    J Neuropathol Exp Neurol; 2009 Jun; 68(6):616-25. PubMed ID: 19458548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E; Pardo LA; Gold R; Linker RA
    Neurobiol Dis; 2008 May; 30(2):162-73. PubMed ID: 18342527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.
    Wujek JR; Bjartmar C; Richer E; Ransohoff RM; Yu M; Tuohy VK; Trapp BD
    J Neuropathol Exp Neurol; 2002 Jan; 61(1):23-32. PubMed ID: 11829341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis.
    Soellner IA; Rabe J; Mauri V; Kaufmann J; Addicks K; Kuerten S
    Clin Immunol; 2013 Dec; 149(3):519-29. PubMed ID: 24239839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
    Pryor WM; Freeman KG; Larson RD; Edwards GL; White LJ
    J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.
    Lev N; Barhum Y; Melamed E; Offen D
    Neurosci Lett; 2004 Apr; 359(3):139-42. PubMed ID: 15050683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Kornek B; Storch MK; Bauer J; Djamshidian A; Weissert R; Wallstroem E; Stefferl A; Zimprich F; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Brain; 2001 Jun; 124(Pt 6):1114-24. PubMed ID: 11353727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and score-dependent.
    Recks MS; Addicks K; Kuerten S
    Neurosci Lett; 2011 May; 494(3):227-31. PubMed ID: 21406210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.